A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy

被引：0
|
作者：
Siming Li [1 ]
Jinchang Wei [1 ]
Huayan Xu [1 ]
Xiaowen Wu [1 ]
Juan Li [1 ]
Li Zhou [1 ]
Xieqiao Yan [1 ]
Bixia Tang [2 ]
Lu Si [2 ]
Chuanliang Cui [2 ]
Zhihong Chi [2 ]
Jun Guo [1 ]
Xinan Sheng [1 ]
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology
[2] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma
来源：
World Journal of Urology | / 43卷 / 1期
关键词：
Prognostic model; Survival; First-line therapy; Upper tract urothelial carcinoma; Metastatic disease;
D O I：
10.1007/s00345-025-05592-7
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [42] Medical oncologists' first-line treatment preferences in metastatic urothelial carcinoma
    Apolo, Andrea B.
    Cambron-Mellott, M. Janelle
    Beusterien, Kathleen
    Seal, Brian S.
    Maculaitis, Martine C.
    Bernstein, Andrew
    Epperson, Megan
    Jeffress, Mara Lisa
    Doleh, Yunes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [43] Reevaluating immunotherapy's potential in first-line metastatic urothelial carcinoma
    Castano-Amores, Celia
    Nieto-Gomez, Pelayo
    JOURNAL OF CHEMOTHERAPY, 2024,
  • [44] Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma
    Miron, Benjamin
    Geynisman, Daniel M.
    EUROPEAN UROLOGY, 2022, 82 (04) : 374 - 376
  • [45] Metastatic urothelial carcinoma of upper urinary tract
    Li, Shau-Hsuan
    Huang, Wan-Ting
    Kuo, Ching-Yuan
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (10) : 940 - 941
  • [46] Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma
    Kolawa, Adam
    D'Souza, Anishka
    Tulpule, Varsha
    CANCERS, 2023, 15 (19)
  • [47] Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting
    de Velasco, Guillermo
    Hamieh, Lana
    Mickey, Suzanne
    Choueiri, Toni K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (12) : 538 - 545
  • [48] Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy
    Galsky, Matt D.
    Moshier, Erin L.
    Krege, Susanne
    Lin, Chia-Chi
    Hahn, Noah M.
    Ecke, Thorsten
    Sonpavde, Guru
    Pond, Gregory Russell
    Godbold, James H.
    Oh, William K.
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [49] Prognostic factors of upper tract urothelial carcinoma
    Elalouf, V.
    Klap, J.
    Delongcharnps, N. -B.
    Conquy, S.
    Sibony, M.
    Saighi, D.
    Peyromaure, M.
    Flam, T.
    Zerbib, M.
    Xylinas, E.
    PROGRES EN UROLOGIE, 2013, 23 (16): : 1382 - 1388
  • [50] Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
    Patil, S.
    Figlin, R. A.
    Hutson, T. E.
    Michaelson, M. D.
    Negrier, S.
    Kim, S. T.
    Huang, X.
    Motzer, R. J.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 295 - 300
12345